Renal Failure

Renal Failure primarily concentrates on acute renal injury and its consequence, but also addresses advances in the fields of chronic renal failure, hypertension, and renal transplantation. Bringing together both clinical and experimental aspects of renal failure, this publication presents timely, practical information on pathology and pathophysiology of acute renal failure; nephrotoxicity of drugs and other substances; prevention, treatment, and therapy of renal failure; renal failure in association with transplantation, hypertension, and diabetes mellitus.

 

This journal uses single-blind peer review.

Renal Failure is a fully open access journal. This means all articles will, if accepted, be available for anyone to read anywhere, at any time immediately on publication. All submitted papers will continue to be peer reviewed following the current rigorous process.   

There is no charge on submission. Authors of accepted papers will pay an article publishing charge (APC) of £1500 / US$1950 / €1725 following peer review. We have agreed a discount on this APC for authors in some institutions (see http://www.tandfonline.com/page/openaccess/members for more details). Editorial Board members are entitled to a 40% discount on their APC providing they alert the Publisher to this on submission of their article.